Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: The invention overcomes the deficiencies of the prior art by providing methods for marker assisted selection to create plants of a soybean variety that exhibit a mid/low linolenic acid content with a commercially significant yield and an agronomically elite phenotype. The invention also provides derivatives and plant parts of these plants. Further provided by the invention are methods for the use of these plants. The invention is significant in that oil with decreased linolenic acid exhibits numerous beneficial characteristics yet prior art varieties with decreased linolenic acid also exhibited decreased yield and poor agronomic quality.

Abstract: The invention overcomes the deficiencies of the art by providing an agronomically elite soybean plant with non-transgenic mutations of at least two of the glycinin subunits selected from the group consisting of Gy1, Gy2, Gy3, Gy4, and Gy5, such as conferring a Gy3 and Gy4 null phenotype and increased ?-conglycinin content in seed. The invention also provides derivatives, and plant parts of these plants and uses thereof. Methods for marker assisted selection of soybean varieties comprising non-transgenic mutations conferring a reduced Gy1, Gy2, Gy3, Gy4, and Gy5 phenotype are also provided as part of the current invention. Methods for producing such plants that are further lipoxygenase and/or Kunitz Trypsin Inhibitor null and the plants produced thereby are also provided. The invention is significant in that soybeans from such plants are preferred dietary additives and provide important health benefits.

Abstract: The preparation and use of nucleic acid fragments encoding fatty acid desaturase enzymes are described. The invention permits alteration of plant lipid composition. Chimeric genes incorporating such nucleic acid fragments with suitable regulatory sequences may be used to create transgenic plants with altered levels of unsaturated fatty acids.

Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.

Abstract: Prostate stem cell antigen (PSCA) is expressed in the majority of prostate cancer patients, making it an ideal target for cancer immunotherapy. Murine monoclonal antibody 1G8 binds to PSCA with nanomolar affinity, but its efficacy as a therapeutic agent is limited by the generation of a HAMA response. The present invention discloses humanized 1G8 antibodies in which the majority of the mouse-derived epitopes have been removed. These humanized antibodies bind PSCA with high affinity and specificity, and have been shown to reduce human bladder tumor take in a nude mouse model. These characteristics make the humanized antibodies of the present invention attractive agents for the treatment and detection of tumors expressing PSCA.

Abstract: The invention overcomes the deficiencies of the prior art by providing methods for marker assisted selection to create plants of a soybean variety that exhibit a mid/low linolenic acid content with a commercially significant yield and an agronomically elite phenotype. The invention also provides derivatives and plant parts of these plants. Further provided by the invention are methods for the use of these plants. The invention is significant in that oil with decreased linolenic acid exhibits numerous beneficial characteristics yet prior art varieties with decreased linolenic acid also exhibited decreased yield and poor agronomic quality.

Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Abstract: A second reaction medium is introduced into a first reaction medium flowing in a flow channel and the reaction media are intensively mixed. The second reaction medium (which may be one or more reaction media) is introduced at a plurality or even a multiplicity of positions that are distributed over a cross section of the flow channel. Turbulence flow is induced in the first reaction medium (which may also be one or more reaction media) at the positions where the second reaction medium is introduced. As a result, the intense mixing of the reaction media with one another takes place directly at the locations where the second reaction medium is introduced into the flow channel.

Abstract: In a first embodiment, this invention relates to a continuously operating press, preferably for the manufacture and/or printing, lamination or the like of a one or multiple layer board web of pre-manufactured material and/or raw material, wherein the lubricant used in the press is at least one phenyl-endblocked polydiorganosiloxane-polyphenylorganosiloxane random copolymer fluid. In a second embodiment, this invention relates to a continuously operating press, preferably for the manufacture and/or printing, lamination or the like of a one or multiple layer board web of pre-manufactured material and/or raw material, wherein the lubricant used in the press is a composition comprising (i) at least one phenyl-endblocked polydiorganosiloxane-polyphenylorganosiloxane random copolymer fluid and (ii) at least one stabilizing agent.

Abstract: In a first embodiment, this invention relates to a continuously operating press, preferably for the manufacture and/or printing, lamination or the like of a one or multiple layer board web of pre-manufactured material and/or raw material, wherein the lubricant used in the press is at least one phenyl-endblocked polydiorganosiloxane-polyphenylorganosiloxane random copolymer fluid. In a second embodiment, this invention relates to a continuously operating press, preferably for the manufacture and/or printing, lamination or the like of a one or multiple layer board web of pre-manufactured material and/or raw material, wherein the lubricant used in the press is a composition comprising (i) at least one phenyl-endblocked polydiorganosiloxane-polyphenylorganosiloxane random copolymer fluid and (ii) at least one stabilizing agent.

Abstract: An optically clear platinum-group metal curable liquid silicone rubber composition having good physical properties. The composition comprises a vinyldimethylsiloxy-terminated polydimethyl(diphenyl)siloxane copolymer comprising about 1 to 20 mole percent diphenylsiloxy units and having a viscosity within a range of about 20,000 mPa.multidot.s to 100,000 mPa.multidot.s at 25.degree. C., vinyldimethylsiloxy-terminated polydimethyl(diphenyl)siloxane copolymer comprising about 1 to 20 mole percent diphenylsiloxy units and having a viscosity within a range of about 50 mPa.multidot.s to 10,000 mPa.multidot.s at 25.degree. C. and optionally comprising up to about 3 mole percent vinyldimethylsiloxy units, a treated reinforcing silica filler, and curing agents.

Abstract: A shoe of mocassin-type wherein the border region of the vamp apron is rolled over the edge of the upper, the vamp apron and the upper being stitched together by a seam having two substantially parallel rows of holes in the border region of the vamp apron and a row of holes which in the finished shoe is situated between the two substantially parallel rows of holes and close to the edge of the upper. In order to ensure in such a shoe perfect fluidtightness of the mocassin seam connecting the vamp apron and the edge of the upper, a sealing strip of resilient compressible material is inserted between the inner row of holes of the vamp apron and the row of holes on the upper, the stitching seam passing through the resilient strip and, in the finished shoe, compressing the strip.